1-16 of 16
Nathalie Javidi-Sharifi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JAK1/2 inhibition with ruxolitinb potentiates ex vivo activity of epcoritamab  in primary CLL cells

Free
Xiao Lyu, Stephanie Chamberlain, Jeremy Zhang, Jing Wang, Nathalie Javidi-Sharifi, Matthew S Davids
Journal: Blood
Blood (2025) 146 (Supplement 1): 2106.
https://doi.org/10.1182/blood-2025-2106
Published: 2025
Journal Articles

A tandem CD19/ROR1 CAR-NK to overcome Wnt5a-mediated apoptotic resistance in chronic lymphocytic leukemia

Free
Salem Elias, Andrew Lu, Fuguo Liu, Xingyu Deng, Olivia Stringham, Jeremy Zhang, Nathalie Javidi-Sharifi, Lara Bencsics, Stephanie Chamberlain, Rizwan Romee, Matthew S Davids
Journal: Blood
Blood (2025) 146 (Supplement 1): 246.
https://doi.org/10.1182/blood-2025-246
Published: 2025
Journal Articles

LIME: A first-in-class of live bacterial immune engagers for cancer immunotherapy

Free
Anna Clara Bader, Shaobo Yang, Ashley Hu, Stephanie Sendker, Daniel Chen, Michal Sheffer, Eden Bobilev, Fuguo Liu, Xingyu Deng, Hetal Nath, Isabel Kaplan, Maily Nyugen, Mila Stanojevic, Mubin Tarannum, Alaa Ali, Roman Shapiro, Young Rock Chung, Erin Parry, Nathalie Javidi-Sharifi, Julissa Tello, Stephanie Dougan, Hermann Einsele, Evelyn Ullrich, John Koreth, Robert Soiffer, Catherine Wu, Jerome Ritz, Rizwan Romee
Journal: Blood
Blood (2025) 146 (Supplement 1): 264.
https://doi.org/10.1182/blood-2025-264
Published: 2025
Journal Articles

Nodal progression in CLL: Real-world predictors of richter transformation and identification of a distinct high-risk NP-CLL subgroup

Free
Nathalie Javidi-Sharifi, Sobana Balasubramanian, Hannah Lee, Paulina Predko, Svitlana Tyekucheva, Amber Mitchell, Stacey Fernandes, Roberta Santos Azevedo, Erin Parry, Catherine Wu, Matthew S Davids, Jennifer Brown
Journal: Blood
Blood (2025) 146 (Supplement 1): 5682.
https://doi.org/10.1182/blood-2025-5682
Published: 2025
Journal Articles

Dual-function engineered bacteria remodel AML tumor microenvironment via IL-12 delivery and adenosine depletion to sustain NK cell immunity

Free
Stephanie Sendker, Shaobo Yang, Anna Clara Bader, Alice Chen, Eden Bobilev, Ashley Hu, Xingyu Deng, Fuguo Liu, Veronica Hui, Maily Nguyen, Andreia Maia, Sara Piccinelli, Kerim Berkay Aslan, Fabian Göllner, Alaa Ali, Remy Dulery, Hetal Nath, Daniel Chen, Mounica Vallurupalli, Andrew Lu, Stephanie Chamberlain, Tereza Kochs, Nathalie Javidi-Sharifi, Michal Sheffer, Roman Shapiro, Andrew Lane, Robert Soiffer, Mubin Tarannum, Jerome Ritz, Rizwan Romee
Journal: Blood
Blood (2025) 146 (Supplement 1): 5912.
https://doi.org/10.1182/blood-2025-5912
Published: 2025
Journal Articles

Pharmacodynamic Analysis of Mcl-1 and RNA Pol II Ser2 Phosphorylation in Blasts from Patients with Relapsed or Refractory Acute Myeloid Leukemia Treated on a Phase 1 Study of Venetoclax Plus Voruciclib

Free
Nathalie Javidi-Sharifi, Jeremy Zhang, Sandra Wiley, Richard G Ghalie, Alexey V. Danilov, Matthew S. Davids
Journal: Blood
Blood (2024) 144 (Supplement 1): 4147.
https://doi.org/10.1182/blood-2024-203689
Published: 2024
Journal Articles

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Free
Yesid Alvarado-Valero, Rachel J. Cook, Shira N. Dinner, Michael Keng, Kebede Begna, Sameem Abedin, MHD Monzr M. Al Malki, Vijaya Raj Bhatt, Nathalie Javidi-Sharifi, Prabhu Rajagopolan, Sandra Wiley, Richard G Ghalie, Matthew S. Davids
Journal: Blood
Blood (2024) 144 (Supplement 1): 2878.
https://doi.org/10.1182/blood-2024-198718
Published: 2024
Journal Articles

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)

Free
Matthew S Davids, Yesid Alvarado Valero, Catherine Diefenbach, Daniel N. Egan, Shira N. Dinner, Monzr M. Al Malki, Kebede Begna, Avyakta Kallam, Sameem Abedin, Rachel Cook, Nathalie Javidi-Sharifi, Edward Dominguez, Lu Miao, Richard G Ghalie, Alexey Danilov
Journal: Blood
Blood (2023) 142 (Supplement 1): 4286.
https://doi.org/10.1182/blood-2023-179577
Published: 2023
Journal Articles

Marrow Stromal Cells Secrete FGF2 in Exosomes, Providing Paracrine Protection for Leukemia Cells from Kinase Inhibitors

Free
Elie Traer, MD PhD, Brian J. Druker, MD, Jakki Martinez, Nathalie Javidi-Sharifi, Isabel English, BA, Anupriya Agarwal, PhD, Jennifer Dunlap, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 306.
https://doi.org/10.1182/blood.V130.Suppl_1.306.306
Published: 2017
Journal Articles

FGF2 from Bone Marrow Stroma Protects Acute Myeloid Leukemia Cells from the FLT3 Inhibitor Quizartinib and Facilitates Acquisition of Resistance Mutations

Free
Elie Traer, MD, Nathalie Javidi-Sharifi, Jacqueline Martinez, MS, Isabel English, Jennifer Dunlap, MD, Anupriya Agarwal, Tibor J. Kovacsovics, MD, Jeffrey W. Tyner, Melissa Wong, PhD, Brian J. Druker, MD
Journal: Blood
Blood (2016) 128 (22): 1080.
https://doi.org/10.1182/blood.V128.22.1080.1080
Published: 2016
Journal Articles

Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation

Free
David K. Edwards, V, BA, BS, Nathalie Javidi-Sharifi, Angela Rofelty, Claire Rosenfeld, Riley Roth-Carter, Paul Tardi, PhD, Lawrence Mayer, PhD, Jeffrey W. Tyner
Journal: Blood
Blood (2016) 128 (22): 5124.
https://doi.org/10.1182/blood.V128.22.5124.5124
Published: 2016
Journal Articles

FGF2-Containing Exosomes Secreted from Bone Marrow Stromal Cells Protect Leukemia Cells from Tyrosine Kinase Inhibitors

Free
Jacqueline Martinez, MS, Nathalie Javidi-Sharifi, Isabel English, Shelton A. Viola, MD, Danielle Jorgens, PhD, Brian J. Druker, MD, Elie Traer, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2465.
https://doi.org/10.1182/blood.V126.23.2465.2465
Published: 2015
Journal Articles

GNB1 Activating Mutations Promote Myeloid and Lymphoid Neoplasms Targetable By Combined PI3K/mTOR Inhibition

Free
Akinori Yoda, PhD, Guillaume Adelmant, PhD, Jerome Tamburini, MD PhD, Bjoern Chapuy, MD PhD, Nobuaki Shindoh, PhD, Yuka Yoda, MPh, Oliver Weigert, MD, Nadja Kopp, MA, Shuo-Chieh Wu, Sunhee S. Kim, Huiyun Liu, Trevor Tivey, Amanda L Christie, Kutlu G Elpek, Joseph Card, Kira Gritsman, MD PhD, Jason Gotlib, MD MS, Michael W. Deininger, Hideki Makishima, MD PhD, Shannon Turley, PhD, Nathalie Javidi-Sharifi, Jaroslaw P. Maciejewski, MD PhD, Scott J Rodig, MD PhD, Jeffrey W. Tyner, Jarrod A Marto, PhD, David M. Weinstock, MD, Andrew A. Lane, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3567.
https://doi.org/10.1182/blood.V124.21.3567.3567
Published: 2014
Journal Articles

Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations

Free
Elie Traer, Nathalie Javidi-Sharifi, Anupriya Agarwal, Jennifer Dunlap, Isabel English, Jacqueline Martinez, Jeffrey W. Tyner, Melissa Wong, Brian J. Druker
Journal: Blood
Blood (2014) 123 (10): 1516–1524.
https://doi.org/10.1182/blood-2013-07-518381
Published: 2014
Includes: Supplemental data
Journal Articles

FGF2 Mediates Resistance In CML Patients In The Absence Of Kinase Domain Mutations, and Resistance Is Overcome By Ponatinib

Free
Elie Traer, MD, PhD, Nathalie Javidi-Sharifi, Anupriya Agarwal, Jennifer B Dunlap, MD, Isabel English, Jacqueline Martinez, Jeffrey W. Tyner, Melissa Wong, PhD, Brian J. Druker
Journal: Blood
Blood (2013) 122 (21): 3983.
https://doi.org/10.1182/blood.V122.21.3983.3983
Published: 2013
Journal Articles

FGF2 Promotes Resistance To Quizartinib In Vitro, and FGF2 Increases In The Marrow Of Patients Prior To Resistance

Free
Elie Traer, MD, PhD, Nathalie Javidi-Sharifi, Anupriya Agarwal, Jennifer B Dunlap, MD, Isabel English, Jacqueline Martinez, Tibor J. Kovacsovics, MD, Jeffrey W. Tyner, Melissa Wong, PhD, Brian J. Druker
Journal: Blood
Blood (2013) 122 (21): 2541.
https://doi.org/10.1182/blood.V122.21.2541.2541
Published: 2013